ReproTech, LLC, the industry leader in human reproductive tissue cryogenic storage, announces its new Scientific Advisory Board.

COCONUT CREEK, Fla. - Oct. 15, 2024 - PRLog -- A pioneer in dedicated reproductive storage with over 30 years of experience, ReproTech specializes in long-term cryostorage and safe transportation of reproductive tissues. The Company, which received a majority investment from Red Barn Equity Partners in 2021, maintains regional facilities in Florida, Minnesota, Nevada, Texas, and Connecticut.

ReproTech's  Scientific Advisory Board will focus on reinforcing the company's dedication to upholding the highest safety and compliance standards in the cryostorage industry.  The Board will provide expert guidance on best practices, regulatory requirements, and innovative approaches to ensure that ReproTech remains the leader in the cryostorage space.  This initiative underscores  ReproTech's commitment to protecting the integrity of stored reproductive tissues and maintaining the trust of its clients.

The board is composed of distinguished experts who bring a wealth of experience and knowledge from the fields of Reproductive Science and Assisted Reproductive Technologies. Each member is deeply committed to ReproTech's mission, serving voluntarily out of a passion for giving back and supporting advancements in these critical areas. Their dedication and expertise play a vital role in driving the organization's initiatives forward.

• Kathleen Hwang, MD, Chairperson - Urologist
• Kyle Orwig, Ph.D – Fertility Preservation Specialist
• Marybeth Gerrity, Ph.D, MBA, HCLD – Reproductive Biologist
• Mark Janzen, Ph.D – Infectious Disease Specialist
• Alison Bartolucci, Ph.D, HCLD – Clinical Reproductive Scientist
• Paul Lin, MD – Reproductive Endocrinologist